E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/30/2006 in the Prospect News Biotech Daily.

Cerus greenshoe exercised, raising equity issue to $45.3 million

By Lisa Kerner

Erie, Pa., March 30 - Cerus Corp. said the underwriters of its follow-on equity offering exercised the 675,000 share over-allotment option in full, raising the size of the deal to $45.3 million.

Cerus originally fixed the terms of its offering at 4.5 million shares of common stock at $11.56 per share on Feb. 27.

Net proceeds to Cerus from the offering were $42.6 million.

Bookrunner and co-lead manager for the Rule 144A deal was Robert W. Baird & Co. Inc., and JMP Securities LLC acted as co-lead manager.

Concord, Calif.-based Cerus is focused on systems to enhance the safety of blood supplies.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.